Advisory Services Network’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.7K Sell
10,760
-4,500
-29% -$13.4K ﹤0.01% 2103
2026
Q1
$47K Buy
15,260
+100
+0.7% +$425 ﹤0.01% 2669
2025
Q4
$54.7K Buy
15,160
+6,200
+69% +$27K ﹤0.01% 1776
2025
Q3
$33.8K Sell
8,960
-7,127
-44% -$27.5K ﹤0.01% 2693
2025
Q2
$59.4K Buy
16,087
+11,500
+251% +$62.2K ﹤0.01% 1720
2025
Q1
$22.9K Buy
+4,587
New +$29.1K ﹤0.01% 1600
2024
Q2
Sell
-26,652
Closed -$271K 1533
2024
Q1
$271K Buy
26,652
+26,552
+26,552% +$270K 0.01% 1194
2023
Q4
$1.13K Buy
+100
New +$418 ﹤0.01% 3508
2017
Q3
Sell
-7
Closed -$1K 2331
2017
Q2
$1K Buy
+7
New +$1.16K ﹤0.01% 2195

Other funds holding ALT

Advisory Services Network's ALT Position: Q2 2026 in Review

Advisory Services Network reduced its Altimmune (ALT) stake by 29% in Q2 2026, selling an estimated $13.4K and leaving 10,760 shares worth $32.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2103.

Advisory Services Network first reported a position in ALT in Q2 2017 and has held it in 9 quarters since. The position peaked at $271K in Q1 2024. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Advisory Services Network held 10,760 shares of Altimmune worth $32.7K as of Q2 2026.
  • Advisory Services Network sold 4,500 Altimmune shares in Q2 2026, an estimated $13.4K.
  • Altimmune made up ﹤0.01% of Advisory Services Network's portfolio in Q2 2026, its #2103 holding.
  • Advisory Services Network first reported a position in Altimmune in Q2 2017 and has held it in 9 quarters since.
  • Advisory Services Network's Altimmune position peaked at $271K in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.